Stocks Sarepta Therapeutics Shares Jump 32% on Expanded FDA Approval for Duchenne Gene Therapy By Investing.comJune 21, 2024 Investing.com – Sarepta Therapeutics (NASDAQ:), a pioneer in genetic precision medicine for rare diseases, saw…
Stocks US FDA approves Merck therapy for rare lung disease From ReutersMarch 26, 2024 Leroy Leo and Michael Erman (Reuters) – The U.S. Food and Drug Administration on Tuesday…
